Medicine: Pharmaceutical companies under scrutiny.

China's pharmaceutical market is plagued by bribery and price fixing. In 2020, the government introduced a review system. Now it will be revised.

EK
27. May 2025

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen

Last updated: 24. July 2025